Vedolizumab: An integrin-receptor antagonist for treatment of Crohn’s disease and ulcerative colitis
Author:
Affiliation:
1. College of Pharmacy, Belmont University, Nashville, TN
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/72/15/1271/28451339/ajhp1271.pdf
Reference28 articles.
1. World Gastroenterology Organization practice guidelines for the diagnosis and management of IBD in 2010;Bernstein;Inflamm Bowel Dis,2010
2. An evidence-based systematic review on medical therapies for inflammatory bowel disease;Talley;Am J Gastroenterol,2011
3. Management of Crohn’s disease in adults;Lichtenstein;Am J Gastroenterol,2009
4. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, practice parameters committee;Kornbluth;Am J Gastroenterol,2010
5. Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population;Kappelman;Dig Dis Sci,2013
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intestinal complications in patients with Crohn’s disease in the Brazilian public healthcare system between 2011 and 2020;World Journal of Clinical Cases;2023-05-16
2. Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment;Current Treatment Options in Gastroenterology;2022-12-06
3. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study;The Lancet Gastroenterology & Hepatology;2022-07
4. Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study;Intestinal Research;2022-01-30
5. Cellular Therapies in Chronic Granulomatous Disease;Frontiers in Pediatrics;2020-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3